• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身性和局部嗜酸性粒细胞增多相一致与鼻息肉患者较差的疾病控制相关。

Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps.

作者信息

Wang Kanghua, Deng Jie, Yang Meng, Chen Yang, Chen Fenghong, Gao Wen-Xiang, Lai Yinyan, Shi Jianbo, Sun Yueqi

机构信息

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.

Guangzhou Key Laboratory of Otorhinolaryngology, Guangzhou, 510080, China.

出版信息

World Allergy Organ J. 2019 Aug 13;12(8):100052. doi: 10.1016/j.waojou.2019.100052. eCollection 2019 Aug.

DOI:10.1016/j.waojou.2019.100052
PMID:31452832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6704051/
Abstract

BACKGROUND

Eosinophilic inflammation is a major phenotype associated with poorly controlled disease in nasal polyp patients. The difference between systemic and local eosinophilia in relation to disease control is poorly understood.

OBJECTIVE

To explore whether blood and polyp tissue eosinophil numbers are independent risk factors for poor disease control in patients with nasal polyp.

METHODS

By using the electronic medical records database and manual evaluation, 183 nasal polyp patients who had undergone endoscopic sinus surgery at least one year prior to the study with complete data of tissue specimens, baseline blood routine test, nasal endoscopy and sinus computed tomography, were identified and recruited to assess disease control based on the criteria of a European position paper on rhinosinusitis and nasal polyps 2012 (EPOS 2012). Multiple logistic regression model was used to determine the association between blood and tissue eosinophil numbers and risk of poor disease control by adjusting for demographics and comorbidities.

RESULTS

We broke down the cohort into 4 groups according to blood (0.3 ​× ​10/L) and tissue (10%) eosinophils. The patients without eosinophilic inflammation represented the largest group (41.5%). The group with concordant blood and tissue eosinophilia represented the second largest (31.2%), and the patients with isolated tissue (15.3%) or blood (12.0%) eosinophilia were relatively rare. Multiple logistic regression models found blood eosinophil count and tissue eosinophil percentage were independently associated with increased risk for poor disease control after adjustments for covariates related to poor treatment outcome. Furthermore, subjects with concordant blood and tissue eosinophilia had a higher risk for poor disease control than those with isolated blood or tissue eosinophilia.

CONCLUSION

Concordant blood and tissue eosinophilia relates to a higher likelihood of poor disease control than isolated blood or tissue eosinophilia after adjustment of potential confounders in nasal polyp patients.

摘要

背景

嗜酸性粒细胞炎症是鼻息肉患者疾病控制不佳的主要表型。关于全身和局部嗜酸性粒细胞增多与疾病控制之间的差异,目前了解甚少。

目的

探讨血液和息肉组织中的嗜酸性粒细胞数量是否是鼻息肉患者疾病控制不佳的独立危险因素。

方法

通过使用电子病历数据库并进行人工评估,确定并招募了183例在研究前至少一年接受过鼻内镜鼻窦手术的鼻息肉患者,这些患者具有组织标本、基线血常规检查、鼻内镜检查和鼻窦计算机断层扫描的完整数据,并根据2012年欧洲鼻窦炎和鼻息肉立场文件(EPOS 2012)的标准评估疾病控制情况。采用多因素logistic回归模型,通过调整人口统计学和合并症因素,确定血液和组织嗜酸性粒细胞数量与疾病控制不佳风险之间的关联。

结果

我们根据血液(0.3×10⁹/L)和组织(10%)嗜酸性粒细胞将队列分为4组。无嗜酸性粒细胞炎症的患者组人数最多(41.5%)。血液和组织嗜酸性粒细胞增多一致的组人数第二多(31.2%),孤立的组织(15.3%)或血液(12.0%)嗜酸性粒细胞增多的患者相对较少。多因素logistic回归模型发现,在调整与治疗效果不佳相关的协变量后,血液嗜酸性粒细胞计数和组织嗜酸性粒细胞百分比与疾病控制不佳风险增加独立相关。此外,血液和组织嗜酸性粒细胞增多一致的受试者比孤立的血液或组织嗜酸性粒细胞增多的受试者疾病控制不佳的风险更高。

结论

在调整鼻息肉患者的潜在混杂因素后,血液和组织嗜酸性粒细胞增多一致比孤立的血液或组织嗜酸性粒细胞增多更易导致疾病控制不佳。

相似文献

1
Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps.全身性和局部嗜酸性粒细胞增多相一致与鼻息肉患者较差的疾病控制相关。
World Allergy Organ J. 2019 Aug 13;12(8):100052. doi: 10.1016/j.waojou.2019.100052. eCollection 2019 Aug.
2
[Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps].[全身和局部嗜酸性粒细胞增多一致与鼻息肉患者疾病控制较差相关]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Oct 7;56(10):1042-1050. doi: 10.3760/cma.j.cn115330-20210428-00235.
3
Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia.根据局部和全身嗜酸性粒细胞增多对鼻息肉患者的术后结局进行炎症特征和预测因素分层。
Int Forum Allergy Rhinol. 2021 May;11(5):846-856. doi: 10.1002/alr.22702. Epub 2020 Oct 4.
4
Molecular and cellular staging for the severity of chronic rhinosinusitis.慢性鼻-鼻窦炎严重程度的分子和细胞分期
Laryngoscope. 2004 Nov;114(11):1895-905. doi: 10.1097/01.mlg.0000147917.43615.c0.
5
Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.组 2 先天淋巴细胞(ILC2)在伴有鼻息肉或嗜酸性粒细胞增多的慢性鼻-鼻窦炎中增加。
Clin Exp Allergy. 2015 Feb;45(2):394-403. doi: 10.1111/cea.12462.
6
[Impact of blood eosinophils on clinical effect of endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps].[血液嗜酸性粒细胞对鼻息肉型慢性鼻窦炎内镜鼻窦手术临床效果的影响]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Sep 7;53(9):680-683. doi: 10.3760/cma.j.issn.1673-0860.2018.09.008.
7
Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population.组织嗜酸性粒细胞增多对中国人群鼻息肉复发的预测意义
Am J Rhinol Allergy. 2015 Sep-Oct;29(5):350-6. doi: 10.2500/ajra.2015.29.4231. Epub 2015 Jul 27.
8
Evaluation of Diffuse Type 2 Dominant or Eosinophilic Chronic Rhinosinusitis With Corticosteroid Irrigation After Surgical Neosinus Cavity Formation.评价手术后新窦腔形成后皮质类固醇冲洗治疗弥漫型 2 型优势或嗜酸性慢性鼻-鼻窦炎。
JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):360-367. doi: 10.1001/jamaoto.2020.5286.
9
Could Eosinophilia predict clinical severity in nasal polyps?嗜酸性粒细胞增多能否预测鼻息肉的临床严重程度?
Multidiscip Respir Med. 2017 Aug 21;12:21. doi: 10.1186/s40248-017-0102-7. eCollection 2017.
10
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size.右普拉克索可减少鼻息肉中的血液和组织嗜酸性粒细胞,而息肉大小无变化。
Laryngoscope. 2019 Feb;129(2):E61-E66. doi: 10.1002/lary.27564. Epub 2018 Oct 4.

引用本文的文献

1
Blood IgE and Eosinophils are not Reliable Predictors of Nasal Tissue Eosinophils in Chronic Rhinosinusitis with Nasal Polyposis.血液中的免疫球蛋白E(IgE)和嗜酸性粒细胞并非慢性鼻-鼻窦炎伴鼻息肉患者鼻组织嗜酸性粒细胞的可靠预测指标。
Int Arch Otorhinolaryngol. 2025 Apr 15;29(2):1-5. doi: 10.1055/s-0044-1801316. eCollection 2025 Apr.
2
Association of mucus eosinophil-derived neurotoxin levels with disease control status in patients with chronic rhinosinusitis.黏液中嗜酸性粒细胞衍生的神经毒素水平与慢性鼻-鼻窦炎患者的疾病控制状况的相关性。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4191-4199. doi: 10.1007/s00405-024-08695-w. Epub 2024 May 3.
3

本文引用的文献

1
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps.慢性鼻-鼻窦炎伴鼻息肉患者的经济负担和资源利用。
Laryngoscope. 2019 Sep;129(9):1969-1975. doi: 10.1002/lary.27852. Epub 2019 Feb 5.
2
The hippo pathway effector Yes-associated protein promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps.河马通路效应物 Yes 相关蛋白促进慢性鼻-鼻窦炎伴鼻息肉中的上皮细胞增殖和重塑。
Allergy. 2019 Apr;74(4):731-742. doi: 10.1111/all.13647. Epub 2018 Nov 18.
3
Prediction models for postoperative uncontrolled chronic rhinosinusitis in daily practice.
Comparison of Long-Term Postoperative Outcomes of the Subtypes of Chronic Rhinosinusitis with Nasal Polyps.
伴鼻息肉的慢性鼻-鼻窦炎各亚型的长期术后结果比较
J Clin Med. 2024 Mar 15;13(6):1699. doi: 10.3390/jcm13061699.
4
Vitamin D Levels in Chronic Rhinosinusitis in Patients With or Without Nasal Polyposis: A Systematic Review.伴有或不伴有鼻息肉的慢性鼻-鼻窦炎患者的维生素D水平:一项系统评价
Cureus. 2023 Sep 30;15(9):e46275. doi: 10.7759/cureus.46275. eCollection 2023 Sep.
5
A novel inflammatory endotype diagnostic model based on cytokines in chronic rhinosinusitis with nasal polyps.一种基于细胞因子的新型炎症内型诊断模型,用于伴鼻息肉的慢性鼻-鼻窦炎。
World Allergy Organ J. 2023 Jul 20;16(7):100796. doi: 10.1016/j.waojou.2023.100796. eCollection 2023 Jul.
6
Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literature.慢性鼻-鼻窦炎疾病控制定义的异质性:科学文献的系统评价
Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5345-5352. doi: 10.1007/s00405-023-08090-x. Epub 2023 Jun 28.
7
Current understanding of disease control and its application in patients with chronic rhinosinusitis.当前对疾病控制的理解及其在慢性鼻-鼻窦炎患者中的应用。
Front Cell Infect Microbiol. 2023 Jun 5;13:1104444. doi: 10.3389/fcimb.2023.1104444. eCollection 2023.
8
Identification of Inflammatory Endotypes by Clinical Characteristics and Nasal Secretion Biomarkers in Chronic Rhinosinusitis with Nasal Polyps.基于临床特征和鼻腔分泌物生物标志物对慢性鼻-鼻窦炎伴鼻息肉患者进行炎症表型分类
Int Arch Allergy Immunol. 2023;184(10):955-965. doi: 10.1159/000530193. Epub 2023 May 30.
9
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis.哮喘和鼻息肉中2型炎症的病理生物学
J Clin Med. 2023 May 9;12(10):3371. doi: 10.3390/jcm12103371.
10
The Role of Nasal Cytology and Serum Atopic Biomarkers in Paediatric Rhinitis.鼻细胞学和血清特应性生物标志物在小儿鼻炎中的作用
Diagnostics (Basel). 2023 Feb 2;13(3):555. doi: 10.3390/diagnostics13030555.
日常实践中术后慢性鼻-鼻窦炎控制不佳的预测模型
Laryngoscope. 2018 Dec;128(12):2673-2680. doi: 10.1002/lary.27267. Epub 2018 Sep 8.
4
Systemic Predictors of Eosinophilic Chronic Rhinosinusitis.嗜酸性粒细胞性慢性鼻-鼻窦炎的全身预测指标
Am J Rhinol Allergy. 2018 Jul;32(4):252-257. doi: 10.1177/1945892418779451. Epub 2018 Jun 4.
5
Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines.通过黏液细胞因子聚类分析鉴定临床相关的慢性鼻-鼻窦炎内型
J Allergy Clin Immunol. 2018 May;141(5):1895-1897.e7. doi: 10.1016/j.jaci.2018.02.002. Epub 2018 Feb 13.
6
Activation state of circulating eosinophils in nasal polyposis.鼻息肉患者循环嗜酸性粒细胞的激活状态。
Int Forum Allergy Rhinol. 2018 May;8(5):584-591. doi: 10.1002/alr.22079. Epub 2018 Jan 15.
7
Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes.慢性鼻-鼻窦炎的多维表型及其与治疗结果的关系。
Allergy. 2018 Jul;73(7):1459-1469. doi: 10.1111/all.13411. Epub 2018 Jan 26.
8
Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response.慢性鼻-鼻窦炎:表型、生物标志物和治疗反应。
J Allergy Clin Immunol. 2017 Dec;140(6):1499-1508. doi: 10.1016/j.jaci.2017.10.006. Epub 2017 Oct 26.
9
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.贝那利珠单抗,一种抗白细胞介素-5 受体 α 的单克隆抗体,作为附加治疗用于严重、未控制、嗜酸性粒细胞性哮喘(CALIMA)患者:一项随机、双盲、安慰剂对照的 3 期试验。
Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5.
10
Chronic Rhinosinusitis with Nasal Polyps.伴鼻息肉的慢性鼻-鼻窦炎
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72. doi: 10.1016/j.jaip.2016.04.012.